Home /
Chemotherapy – University Hospital Vrije Universiteit
|
|
Description: |
Patients: This Phase II trial involved 41 patients with malignant pleural mesothelioma.
Treatment: The treatment consisted of a chemotherapy drug, oral etoposide (VP 16-213, vepesid). Toxicity: Grade 3-4 toxicities included hematological, nausea/vomiting, cutaneous reaction, and alopecia. Results: Median survival was 38 weeks (8.8 months). |